PL3219321T3 - Zrębowe komórki macierzyste pochodzące z tkanki tłuszczowej do zastosowania do leczenia opornych złożonych przetok okołoodbytowych w chorobie leśniowskiego-crohna - Google Patents

Zrębowe komórki macierzyste pochodzące z tkanki tłuszczowej do zastosowania do leczenia opornych złożonych przetok okołoodbytowych w chorobie leśniowskiego-crohna

Info

Publication number
PL3219321T3
PL3219321T3 PL17160932T PL17160932T PL3219321T3 PL 3219321 T3 PL3219321 T3 PL 3219321T3 PL 17160932 T PL17160932 T PL 17160932T PL 17160932 T PL17160932 T PL 17160932T PL 3219321 T3 PL3219321 T3 PL 3219321T3
Authority
PL
Poland
Prior art keywords
crohn
disease
stem cells
adipose tissue
derived stromal
Prior art date
Application number
PL17160932T
Other languages
English (en)
Inventor
Eduardo BRAVO
Maria PASCUAL
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of PL3219321T3 publication Critical patent/PL3219321T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL17160932T 2016-03-14 2017-03-14 Zrębowe komórki macierzyste pochodzące z tkanki tłuszczowej do zastosowania do leczenia opornych złożonych przetok okołoodbytowych w chorobie leśniowskiego-crohna PL3219321T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1604304.4A GB201604304D0 (en) 2016-03-14 2016-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP17160932.4A EP3219321B1 (en) 2016-03-14 2017-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease

Publications (1)

Publication Number Publication Date
PL3219321T3 true PL3219321T3 (pl) 2022-05-30

Family

ID=55952284

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17160932T PL3219321T3 (pl) 2016-03-14 2017-03-14 Zrębowe komórki macierzyste pochodzące z tkanki tłuszczowej do zastosowania do leczenia opornych złożonych przetok okołoodbytowych w chorobie leśniowskiego-crohna

Country Status (26)

Country Link
US (3) US10357518B2 (pl)
EP (2) EP4074322A1 (pl)
JP (2) JP6931656B2 (pl)
KR (1) KR102277789B1 (pl)
CN (2) CN115569151A (pl)
AU (1) AU2017232718B2 (pl)
BE (1) BE1024781B1 (pl)
CA (1) CA3017694C (pl)
DE (1) DE102017002458B4 (pl)
DK (1) DK3219321T3 (pl)
ES (2) ES2681774B1 (pl)
FR (1) FR3048614B1 (pl)
GB (2) GB201604304D0 (pl)
HR (1) HRP20220539T1 (pl)
HU (1) HUE058739T2 (pl)
IL (2) IL261730B2 (pl)
LT (1) LT3219321T (pl)
MX (1) MX2018010699A (pl)
NL (1) NL2018512B1 (pl)
NO (1) NO345415B1 (pl)
PL (1) PL3219321T3 (pl)
RS (1) RS63163B1 (pl)
RU (1) RU2742308C2 (pl)
SG (2) SG10202008992YA (pl)
SI (1) SI3219321T1 (pl)
WO (1) WO2017158509A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
CA3054947A1 (en) 2017-03-30 2018-10-04 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with live biotherapeutics
CA3127851A1 (en) * 2019-02-27 2020-09-03 Tigenix, S.A.U. Improved stem cell populations for allogeneic therapy
KR20220152240A (ko) * 2020-03-11 2022-11-15 메조블라스트 인터내셔널 에스에이알엘 염증성 장 질환 ii의 치료 방법
AU2021234104A1 (en) * 2020-03-11 2022-09-29 Mesoblast International Sàrl Method for treating inflammatory bowel disease I
CN111481573A (zh) * 2020-03-26 2020-08-04 卡替（上海）生物技术股份有限公司 牙髓间充质干细胞在制备克罗恩病治疗药物中的用途
US20240009249A1 (en) * 2020-11-25 2024-01-11 Flagship Pioneering, Inc. Adipogenic cell compositions and methods
WO2023230524A1 (en) * 2022-05-25 2023-11-30 Flagship Pioneering Innovations Vi, Llc Compositions of secretory and/or catalytic cells and methods using the same

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
EP0672033B1 (en) 1992-12-02 1998-03-11 Shell Internationale Researchmaatschappij B.V. Azoxycyanobenzene derivatives
WO1995002698A1 (en) 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
US5472183A (en) 1994-03-17 1995-12-05 Nisca Corporation Sheet feeding device with multiple sheet stackers
DK0952792T3 (da) 1994-06-06 2003-12-08 Osiris Therapeutics Inc Biomatrix til vævsregeneration
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
CA2222328C (en) 1995-06-07 2012-01-10 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US6546106B2 (en) 1996-09-03 2003-04-08 New Transducers Limited Acoustic device
US5705308A (en) 1996-09-30 1998-01-06 Eastman Kodak Company Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element
CN100529063C (zh) 1997-12-02 2009-08-19 泽恩比奥公司 使脂肪基质细胞分化为成骨细胞的方法
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US9585916B2 (en) 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
ES2205792T3 (es) 1998-04-03 2004-05-01 Osiris Therapeutics, Inc. Celulas madre mesenquimatosas como inmunosupresores.
US6546105B1 (en) 1998-10-30 2003-04-08 Matsushita Electric Industrial Co., Ltd. Sound image localization device and sound image localization method
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
CA2366078C (en) 1999-03-10 2015-09-01 University Of Pittsburgh Of The Commonwealth System Of Higher Education Adipose-derived stem cells and lattices
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
WO2002067867A2 (en) 2001-02-23 2002-09-06 The University Of Pittsburgh Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
HUP0500699A3 (en) * 2001-11-09 2010-01-28 Artecel Sciences Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
US20030152558A1 (en) 2001-11-09 2003-08-14 Christopher Luft Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
CN100579577C (zh) 2002-03-15 2010-01-13 退伍军人事务研发服务部 使用细胞脱唾液酸决定簇和糖缀合物将细胞靶向组织和器官的方法和组合物
EP1990350A1 (en) 2002-06-14 2008-11-12 Cartela R&D AB Marker for mesenchymal stem cells and its use
US20040101959A1 (en) 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
DE602004029337D1 (de) 2003-04-01 2010-11-11 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
PL1641914T3 (pl) 2003-06-27 2017-01-31 DePuy Synthes Products, Inc. Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
US7645229B2 (en) 2003-09-26 2010-01-12 Armstrong David N Instrument and method for endoscopic visualization and treatment of anorectal fistula
JP4749331B2 (ja) 2003-10-07 2011-08-17 株式会社バイオマスター 脂肪由来前駆細胞の細胞分化
KR100821128B1 (ko) 2003-11-04 2008-04-14 가부시키가이샤 바이오마스타 지방 조직으로부터 줄기세포를 생성하는 방법 및 시스템
CA2564679C (en) 2004-03-22 2015-06-23 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
RU2252252C1 (ru) 2004-04-09 2005-05-20 Тепляшин Александр Сергеевич Способ выделения мезенхимальных стволовых клеток
ES2313805B1 (es) 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2264862B8 (es) 2004-08-25 2017-01-20 Cellerix, S.L. Biomaterial para sutura.
WO2006029347A2 (en) 2004-09-03 2006-03-16 University Of Maryland, Baltimore Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
CN101313062A (zh) 2005-09-23 2008-11-26 塞勒里克斯有限公司 具有免疫调节活性的细胞群及其分离方法和用途
EP1795588A1 (en) 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
WO2008036374A2 (en) 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
EP2191835A4 (en) 2007-09-07 2011-12-14 Japan Chem Res THERAPEUTIC AND PROPHYLACTIC AGENTS FOR ARTHRITIS
PL2200622T5 (pl) 2007-09-19 2016-08-31 Pluristem Ltd Adherentne komórki z tkanki tłuszczowej i łożyska i ich zastosowanie w terapii
RU2493869C2 (ru) 2007-10-17 2013-09-27 ТИксСЕЛЛ Tr1-КЛЕТКИ, МЕЗЕНХИМАЛЬНЫЕ СТВОЛОВЫЕ КЛЕТКИ И ИХ ПРИМЕНЕНИЕ
GB0814249D0 (en) 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
ES2345867B1 (es) * 2009-04-03 2011-07-28 Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) Celulas madre multipotentes derivadas de estroma de mesenterio.
ES2479621T3 (es) * 2009-04-28 2014-07-24 Anterogen Co., Ltd. Composición de células madre estromales derivadas de tejido adiposo autólogo y alogénico destinada al tratamiento de fístulas
NZ597975A (en) 2009-07-09 2014-06-27 Tigenix S A Methods and compositions for use in cellular therapies
WO2012078536A2 (en) * 2010-12-06 2012-06-14 Quark Pharmaceuticals, Inc. Double stranded oligonucleotide compounds comprising positional modifications
EP2663316A2 (en) 2011-01-12 2013-11-20 TiGenix, S.A.U. Adipose-derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases
KR20140016933A (ko) 2011-03-11 2014-02-10 타이제닉스, 에스.에이.유. 면역조절 활성을 갖는 세포군, 분리방법 및 용도들
US20140134140A1 (en) 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
PL2972368T3 (pl) * 2013-03-15 2020-03-31 Tigenix, S.A.U. Biomarkery limfocytów do określania odpowiedzi klinicznej na terapię komórkową
WO2014207679A1 (en) 2013-06-25 2014-12-31 Tigenix S.A.U. Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
JP6722599B2 (ja) * 2014-06-30 2020-07-15 ティジェニクス エス．エー．ユー． 全身性炎症反応症候群の治療のための間葉系間質細胞
CN108138142A (zh) * 2015-09-24 2018-06-08 塞莱克特生物疗法有限公司 繁殖用在移植中的间质干细胞（msc）的方法
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease

Also Published As

Publication number Publication date
NO345415B1 (en) 2021-01-18
BR112018068493A2 (pt) 2019-01-22
JP6931656B2 (ja) 2021-09-08
CN108883135A (zh) 2018-11-23
BE1024781A1 (de) 2018-06-27
GB2548490B (en) 2020-09-02
RU2018131519A (ru) 2020-04-15
EP3219321A1 (en) 2017-09-20
IL261730A (en) 2018-10-31
IL298107B2 (en) 2024-02-01
MX2018010699A (es) 2019-01-14
RU2742308C2 (ru) 2021-02-04
US20170258851A1 (en) 2017-09-14
FR3048614B1 (fr) 2020-02-21
AU2017232718B2 (en) 2024-01-18
WO2017158509A1 (en) 2017-09-21
NO20170376A1 (en) 2017-09-15
ES2911718T3 (es) 2022-05-20
US20190381106A1 (en) 2019-12-19
RU2018131519A3 (pl) 2020-07-10
GB2548490A (en) 2017-09-20
DE102017002458A1 (de) 2017-09-14
BR112018068493A8 (pt) 2022-06-28
RS63163B1 (sr) 2022-05-31
SI3219321T1 (sl) 2022-05-31
GB201704065D0 (en) 2017-04-26
CA3017694C (en) 2024-02-27
ES2681774B1 (es) 2019-12-26
BE1024781B1 (de) 2018-07-02
US11273182B2 (en) 2022-03-15
EP4074322A1 (en) 2022-10-19
SG11201807404XA (en) 2018-09-27
ES2681774A1 (es) 2018-09-14
IL298107A (en) 2023-01-01
JP2021119789A (ja) 2021-08-19
HRP20220539T1 (hr) 2022-06-10
DK3219321T3 (da) 2022-04-25
CN115569151A (zh) 2023-01-06
IL261730B1 (en) 2024-01-01
DE102017002458B4 (de) 2019-04-25
LT3219321T (lt) 2022-05-10
EP3219321B1 (en) 2022-03-30
CN108883135B (zh) 2022-11-04
AU2017232718A1 (en) 2018-10-04
KR102277789B1 (ko) 2021-07-15
IL261730B2 (en) 2024-05-01
SG10202008992YA (en) 2020-10-29
US10357518B2 (en) 2019-07-23
JP2019508455A (ja) 2019-03-28
HUE058739T2 (hu) 2022-09-28
NL2018512A (en) 2017-03-30
GB201604304D0 (en) 2016-04-27
FR3048614A1 (pl) 2017-09-15
NL2018512B1 (en) 2017-09-07
CA3017694A1 (en) 2017-09-21
KR20180120261A (ko) 2018-11-05
US20220249574A1 (en) 2022-08-11
IL298107B1 (en) 2023-10-01

Similar Documents

Publication Publication Date Title
GB2548490B (en) Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
SG10201606170SA (en) Estimating Vessel Intent
IL236054B (en) Compositions and methods for treating Crohn's disease and related conditions and infections
EP3384007C0 (en) IMPROVED METHODS FOR REPROGRAMMING NON-PLURIPOTENT CELLS INTO PLURIPOTENT STEM CELLS
PL3084009T3 (pl) Lactobacillus salivarius do leczenia stanu zapalnego sutka
ZA202203445B (en) Compositions for use in treating hypoxia inducible factor (hif)-related conditions
HUE057257T2 (hu) Folyékony készítmény gyomor- és nyelõcsõ reflux kezelésében történõ alkalmazásra
IL250980A0 (en) Mucolytic agents for use in the treatment of pulmonary sarcoidosis
HUE037916T2 (hu) Laktoferrin Alzheimer-kór diagnózisában és prognózisában történõ alkalmazására
ZA201701330B (en) Use of cysteamine in treating infections caused by yeasts / moulds
FR3020758B1 (fr) Composition pour ameliorer l'hygiene buco-dentaire
IL251605B (en) Use of protein in predicting intra-corporeal phenomena
EP3381458C0 (en) THERAPEUTIC AGENT FOR LIVER DISEASE COMPRISING STOROMAL CELLS DERIVED FROM Adipose TISSUE, AND METHOD FOR PRODUCING THE SAME THERAPEUTIC AGENT
FR3030253B1 (fr) Composition pour ameliorer l'aspect cellulitique de la peau
HUE055086T2 (hu) Eljárás másodlagos alumínium olvasztási salak kezelésére
GB201402543D0 (en) Multipotent stromal cell loaded microcarriers
IL252109A0 (en) (pigment epithelium derived factor (pedf) for the treatment of uterine fibroids
ZA201703246B (en) Genetic markers for determining ectoparasite susceptibility to acaricides
PT3191106T (pt) Composição compreendendo uma microalga enriquecida em silício para uma utilização terapêutica
IL256880A (en) Combining proteins for the diagnosis of schizophrenia
IL257342A (en) Lisobactin for use in the treatment of udder inflammation in cattle
IL251040A0 (en) Using cysteamine to treat infections caused by yeasts/molds
TWM489511U (en) The underpants for improving the abilities of men in sexing
ZA201408464B (en) Composition for the use in treatment of asthma
GB201409557D0 (en) Tub and bucket trolley